January 20, 2026

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Strong Buy Ratings and 50% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company focused on rare kidney and metabolic diseases, has become a compelling point of interest for investors, showcasing a potential upside of 50.44%..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 6.43% Potential Upside in a Dynamic Healthcare Landscape

Bausch Health Companies Inc. (BHC), a prominent player in the healthcare sector, operates a diversified portfolio that spans specialty pharmaceuticals and medical devices. With a market capitalization of $2.59 billion,..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Growth in Senior Care with a 7.58% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, is making waves in the medical care facilities industry with its robust portfolio of senior living communities...

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech Gem with a 27.70% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE), a rising star in the biotechnology sector, is captivating investor attention with its promising pipeline and a substantial upside potential of 27.70%, according to analyst..

CG Oncology, Inc. (CGON) Stock Analysis: A Biotech Powerhouse with 41.87% Potential Upside

CG Oncology, Inc. (CGON) is making waves in the biotechnology sector, drawing significant attention from investors with its robust pipeline of bladder cancer treatments. Headquartered in Irvine, California, this late-stage..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 48.90% Potential Upside in Healthcare Innovation

Schrödinger, Inc. (NASDAQ: SDGR) stands at the intersection of healthcare and technology, offering compelling prospects for individual investors. With a current market capitalization of $1.24 billion, this New York-based player..

NewAmsterdam Pharma (NAMS) Stock Analysis: Evaluating the 52.72% Potential Upside

NewAmsterdam Pharma Company N.V. (NAMS), a notable player in the biotechnology sector, has captured investor attention with its promising potential upside of 52.72%. This Dutch biopharmaceutical firm is dedicated to..

GeneDx Holdings Corp. (WGS) Stock Analysis: Navigating a 58% Potential Upside in the Genomics Space

GeneDx Holdings Corp. (NYSE: WGS) stands at the forefront of the healthcare sector’s promising genomics industry, with its specialized focus on genetic testing services. As a company with a significant..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A 39% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising player in the biotechnology sector, presents an intriguing opportunity for investors focused on innovative healthcare solutions. With a market capitalization of $2.9 billion,..

Select Medical Holdings Corp (SEM) Stock Analysis: Unpacking a 19.79% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM), a significant player in the healthcare sector, has captured investor attention with its robust growth potential and operational footprint across the United States. As..

Denali Therapeutics Inc. (DNLI)

⚠️ No article content returned.

..

BioCryst Pharmaceuticals, Inc. (BCRX): Investor Outlook with 207% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a notable player in the healthcare sector, is making waves with its promising pipeline and remarkable potential upside. Specializing in the development of oral small-molecule..

Progyny, Inc. (PGNY) Stock Analysis: Unpacking a 24% Upside Potential in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY) continues to capture the attention of investors with its innovative approach to fertility and family-building benefits. As a healthcare plans provider specializing in fertility solutions, Progyny..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A 67.91% Potential Upside with Strong Buy Ratings

Kymera Therapeutics, Inc. (NASDAQ: KYMR) has captured investor attention with its innovative approach in the biotechnology sector. This clinical-stage biopharmaceutical company, headquartered in Watertown, Massachusetts, is pioneering in the field..

HUTCHMED (China) Limited (HCM): Investor Outlook on a 39.47% Upside in the Growing Oncology Market

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, is making waves in the pharmaceutical industry with its innovative approach to cancer treatment. With a market capitalization..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Leader with 26% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the biotechnology sector with its robust pipeline and promising valuation metrics. With a market capitalization of $3.8 billion, this U.S.-based biotech..

Harmony Biosciences Holdings, Inc. (HRMY): Growth Prospects and a 27% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is capturing investor attention with its solid growth trajectory and promising pipeline in the biotechnology sector. With a market capitalization of $2.09 billion, the..

Addus HomeCare Corporation (ADUS): Investor Outlook Highlights Strong Growth Potential with 31.16% Upside

Addus HomeCare Corporation (NASDAQ: ADUS) presents a compelling opportunity for investors within the healthcare sector, particularly in the medical care facilities industry. With a market capitalization of approximately $1.99 billion,..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 14.67% Potential Upside in the Healthcare Diagnostics Sector

For investors eyeing opportunities in the healthcare diagnostics sector, Veracyte, Inc. (NASDAQ: VCYT) presents a compelling case. With a market capitalization of $3.29 billion, Veracyte’s innovative diagnostic solutions are making..

LeMaitre Vascular, Inc. (LMAT) Stock Report: Analyzing 17.44% Potential Upside with Strong Revenue Growth

LeMaitre Vascular, Inc. (NASDAQ: LMAT) has captured investor attention with its robust presence in the medical instruments and supplies sector. With a market capitalization of $2 billion, this Burlington, Massachusetts-based..

Search

Funds

January 20, 2026

Search

Funds

January 20, 2026

FTSE 100

Funds